Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease
Clinical and Experimental Dermatology · 2023
DOI: 10.1093/ced/llac077 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Experimental Dermatology, 2023. Verfasst von Thilo Gambichler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany; and. Hauptthemen laut MEDLINE: Epidermolysis Bullosa Acquisita, Crohn Disease, Epidermolysis Bullosa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
A 32-year-old man with a long history of Crohn disease was put on ustekinumab, and after about 1 year of treatment, developed blisters and inflammatory lesions. He was diagnosed with epidermolysis bullosa acquisita and treated with dapsone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany; and.
- Department of Dermatology and Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
ORCID-Profile: Thilo Gambichler
Zitieren
APA
Gambichler, T., Schmidt, E., Scheel, C. H., & Chatzipantazi, M. (2023). Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llac077
Vancouver
Gambichler T, Schmidt E, Scheel CH, Chatzipantazi M. Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease. Clinical and Experimental Dermatology. 2023. doi:10.1093/ced/llac077
BibTeX
@article{Gambichler2023,
author = {Gambichler, Thilo and Schmidt, E and Scheel, Christina H and Chatzipantazi, Maria},
title = {Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease},
journal = {Clinical and Experimental Dermatology},
year = {2023},
doi = {10.1093/ced/llac077}
}
EUVIMED